Skip to main content
All lobbying filings

THORN RUN PARTNERS

Lobbying for EXELIXIS · Genomics-based drug discovery company

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $60,000.00 income · posted Apr 18, 2026

Official filing document

 Lobbying activity 2
Health Issues

Policies related to creating incentives for innovation in the life sciences.

Medicare/Medicaid

Tracking implementation of prescription drug pricing policies included as part of the Inflation Reduction Act (IRA).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem